Literature DB >> 14693838

Histopathological patterns of melanoma metastases in sentinel lymph nodes.

C A Murray1, W L Leong, D R McCready, D M Ghazarian.   

Abstract

AIMS: Sentinel lymph node biopsy (SLNB) is an important component in the staging and treatment of cutaneous melanoma (CM). The medical literature provides only limited information regarding melanoma sentinel lymph node (SLN) histology. This report details the specific histological patterns of melanoma metastases in sentinel lymph nodes (SLNs) and highlights some key factors in evaluating SLNs for melanoma.
METHODS: From 281 SLNB cases between June 1998 and May 2002, 79 consecutive cases of SLN biopsies positive for metastases from CM were retrospectively reviewed. The important characteristics of the SLNs and the metastatic foci are described.
RESULTS: The median size of positive SLNs was 17 mm (range, 5-38). SLNs had a median of two metastatic foci (range, 1-11), with the largest foci being a median of 1.1 mm in size (range, 0.05-24). S-100 and HMB-45 staining was positive in 100% and 92% of the detected metastatic foci, respectively. The metastatic melanoma cells were epithelioid, spindled, and mixed in 86%, 5%, and 9% of cases. Metastatic foci were most often (86%) found in the subcapsular region of the SLN. Benign naevic cells were found coexisting in 14% of positive SLNs.
CONCLUSIONS: Staining for S100 is more sensitive than HMB-45 (100% v 92%), but HMB-45 staining helped to distinguish benign naevic cells from melanoma. The subcapsular region was crucial in SLN evaluation, because it contained the metastases in 86% of cases. Evaluation of the subcapsular space should not be compromised by cautery artefacts or incomplete excision of the SLN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693838      PMCID: PMC1770187          DOI: 10.1136/jcp.57.1.64

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  33 in total

Review 1.  Sentinel node biopsy in the management of malignant melanoma.

Authors:  R Russell-Jones; K Acland
Journal:  Clin Exp Dermatol       Date:  2001-09       Impact factor: 3.470

2.  Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy.

Authors:  Jaime M Ranieri; Jeffrey D Wagner; Rafael Azuaje; D Davidson; Stacie Wenck; Joanne Fyffe; John J Coleman
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

3.  The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

Authors:  M G Statius Muller; P A van Leeuwen; E S de Lange-De Klerk; P J van Diest; R Pijpers; C C Ferwerda; R J Vuylsteke; S Meijer
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

4.  Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.

Authors:  Rebekah R White; Wilma E Stanley; Jeffrey L Johnson; Douglas S Tyler; Hilliard F Seigler
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

Review 5.  Current practice and future directions in pathology and laboratory evaluation of the sentinel node.

Authors:  A J Cochran; R R Huang; J Guo; D R Wen
Journal:  Ann Surg Oncol       Date:  2001-10       Impact factor: 5.344

6.  A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.

Authors:  H Starz; B R Balda; K U Krämer; H Büchels; H Wang
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

7.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

Review 8.  Sentinel lymph node biopsy in patients with melanoma and breast cancer.

Authors:  R F Uren; J F Thompson; R Howman-Giles
Journal:  Intern Med J       Date:  2001-12       Impact factor: 2.048

9.  Sentinel lymph-node biopsy after previous wide local excision for melanoma.

Authors:  D R McCready; D M Ghazarian; M S Hershkop; J A Walker; U Ambus; I C Quirt
Journal:  Can J Surg       Date:  2001-12       Impact factor: 2.089

10.  Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.

Authors:  Tarik Belhocine; Gérald Pierard; Michel De Labrassinne; Thierry Lahaye; Pierre Rigo
Journal:  Oncologist       Date:  2002
View more
  9 in total

1.  Optical clearing based cellular-level 3D visualization of intact lymph node cortex.

Authors:  Eunjoo Song; Howon Seo; Kibaek Choe; Yoonha Hwang; Jinhyo Ahn; Soyeon Ahn; Pilhan Kim
Journal:  Biomed Opt Express       Date:  2015-09-28       Impact factor: 3.732

2.  Intracapsular melanoma: a new pitfall for sentinel lymph node biopsy.

Authors:  B G Howell; J E Lipa; D M Ghazarian
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Dynamic 18F-FDG PET Lymphography for In Vivo Identification of Lymph Node Metastases in Murine Melanoma.

Authors:  Hannah Lockau; Volker Neuschmelting; Anuja Ogirala; Antoni Vilaseca; Jan Grimm
Journal:  J Nucl Med       Date:  2017-09-14       Impact factor: 10.057

4.  Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.

Authors:  Jad Saab; Maria Laureana Santos-Zabala; Massimo Loda; Edward C Stack; Travis J Hollmann
Journal:  Am J Dermatopathol       Date:  2018-04       Impact factor: 1.533

5.  Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model.

Authors:  Onkar V Khullar; Aaron P Griset; Summer L Gibbs-Strauss; Lucian R Chirieac; Kimberly A V Zubris; John V Frangioni; Mark W Grinstaff; Yolonda L Colson
Journal:  J Am Coll Surg       Date:  2012-01-05       Impact factor: 6.113

6.  Deciduosis in a cesarean scar.

Authors:  Toyaja Jadhav; Rohini Doshetty
Journal:  Autops Case Rep       Date:  2022-05-06

7.  Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.

Authors:  Scott R Dalton; Pedram Gerami; Nicholas A Kolaitis; Susan Charzan; Rob Werling; Philip E LeBoit; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

Review 8.  Tumor-Derived Apoptotic Vesicles: With Death They Do Part.

Authors:  Morad-Remy Muhsin-Sharafaldine; Alexander D McLellan
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

9.  Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data.

Authors:  Lazaro Hiram Betancourt; Krzysztof Pawłowski; Jonatan Eriksson; A Marcell Szasz; Shamik Mitra; Indira Pla; Charlotte Welinder; Henrik Ekedahl; Per Broberg; Roger Appelqvist; Maria Yakovleva; Yutaka Sugihara; Kenichi Miharada; Christian Ingvar; Lotta Lundgren; Bo Baldetorp; Håkan Olsson; Melinda Rezeli; Elisabet Wieslander; Peter Horvatovich; Johan Malm; Göran Jönsson; György Marko-Varga
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.